(Q80223517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Anaphylactic reaction after initial exposure of Basiliximab: case reports (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

H Sasaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Chikaraishi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

S Furuhata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

H Tsutsumi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

S Miyano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Nakano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Y Sato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

K Kimura

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Takahashi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

3457-3459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.104

Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.104

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.104

Relevant targets for therapy with monoclonal antibodies in allograft transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.104

The IgE humoral response in OKT3-treated patients. Incidence and fine specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.104

Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.104

The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.104

10.1016/J.TRANSPROCEED.2007.08.104

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18089406%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference